Cenerimod, a novel selective S1P₁ receptor modulator with unique signaling properties.

Therapeutic intervention, ie when dosing was initiated at the peak of disease induction, showed a trend to ameliorate disease scores, although statistical significance was not reached.

also in 53,322 other papers